Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the CorMedix, Inc. Securities Class Action Lawsuit - CRMD
02:04am, Tuesday, 17'th Aug 2021
San Diego, California--(Newsfile Corp. - August 17, 2021) - Robbins Geller Rudman & Dowd LLP announces that the CorMedix securities class action lawsuit charges CorMedix, Inc. (NASDAQ: CRMD) and certa
New York, New York--(Newsfile Corp. - August 16, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CorMedix Inc. (NASDAQ: CRMD) alleging
New York, New York--(Newsfile Corp. - August 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
Los Angeles, California--(Newsfile Corp. - August 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CorMedix Inc. ("Co
New York, New York--(Newsfile Corp. - August 13, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8, 20
Los Angeles, California--(Newsfile Corp. - August 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CorMedix Inc. ("Co
CorMedix Inc. (CRMD) CEO Khoso Baluch on Q2 2021 Results - Earnings Call Transcript
08:09pm, Thursday, 12'th Aug 2021
CorMedix Inc. (CRMD) CEO Khoso Baluch on Q2 2021 Results - Earnings Call Transcript
CorMedix (CRMD) Reports Q2 Loss, Lags Revenue Estimates
07:19pm, Thursday, 12'th Aug 2021
CorMedix (CRMD) delivered earnings and revenue surprises of 33.33% and -89.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Los Angeles, California--(Newsfile Corp. - August 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CorMedix Inc. ("Co
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD)
11:00am, Thursday, 12'th Aug 2021
LOS ANGELES, Aug. 12, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming September 20, 2021 deadline to file a lead plaintiff motion in the class action fi
CLASS ACTION UPDATE for SRAC, CRMD and OTLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
05:40am, Thursday, 12'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholde
NEW YORK , Aug. 11, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. ("CorMedix" or the "Company") (NASDAQ: CRMD) and certain of its office
SAN DIEGO, Aug. 11, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the CorMedix class action lawsuit charges CorMedix Inc. (NASDAQ: CRMD) and certain of its top executives with
New York, New York--(Newsfile Corp. - August 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CorMedix Inc. (CRMD) Investors
11:40am, Wednesday, 11'th Aug 2021
LOS ANGELES, Aug. 11, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired
